ClinicalTrials.gov
public full text
Public Domain
A Study of LY2140023 in Healthy Males and Females
The study will evaluate the effect of different particle size of LY2140023. The study involves 4 single doses of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth with a washout period of at least 3 days between doses. This study will last approximately 60 days not including screening. Screening is required within 30 days prior to study entry.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY2409021 in Healthy Participants#1010011
- A Study of LY3463251 in Healthy Participants#906560
- A Study of LY3127760 in Healthy Participants#877420
- A Study of LY4302814 in Healthy Participants#1058487
- A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children#1088733
Record · ID 1497766
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive